Trial Profile
Menopausal Sleep Fragmentation: Impact on Body Fat Gain Biomarkers in Women
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Aug 2023
Price :
$35
*
At a glance
- Drugs Leuprorelin (Primary)
- Indications Menopause
- Focus Therapeutic Use
- 08 Nov 2022 Status changed from active, no longer recruiting to completed.
- 08 Apr 2022 Planned End Date changed from 1 Mar 2022 to 1 Jul 2022.
- 08 Apr 2022 Planned primary completion date changed from 1 Dec 2021 to 1 Jul 2022.